Eric Rothman

Partner

Arnold & Porter

Office Phone:

(212) 836-8000

Direct Phone:

(212) 836-7737


  Pro - Try 1 Week Free
 

    and access,

  •     81K PE/M&A Contacts
  •     +
  •     4.6K PE Firms
  •     3.6K M&A Advisors
  •     200K Transactions
  •     203K Companies

  •     Market Services
  •     Build Lists
  •     Research Sectors
  •     Uncover Opportunities

Bio

Eric Rothman's practice focuses on a wide variety of life sciences transactions, for both foreign and domestic clients, representing many of the world's most sophisticated life sciences companies. Mr. Rothman's clients range from early-stage biotechs to major international pharmaceutical companies, including businesses involved with drug development and manufacturing, biologics, biosimilars and other biotech products, generics and 505(b)(2) products, vaccines and diagnostics, and medical devices. Major clients include AstraZeneca, Novartis, Sandoz, Alcon, Pfizer, Celgene, Purdue Pharma, and Mundipharma. Mr. Rothman has experience structuring and negotiating transactions for both branded and generic products, including research collaborations and license agreements, university licenses and sponsored research agreements, option agreements, pre-clinical research agreements, material transfer agreements, licenses and co-development collaborations, clinical research agreements, contract research organization (CRO) agreements, co-promotion/co-development alliances, marketing and distribution agreements, product acquisitions and divestitures, manufacturing and supply agreements, transition service agreements, pharmacovigilance agreements, contract sales organization (CSO) agreements, and various other corporate partnering structures. Mr. Rothman also counsels clients on contentious transactional matters, including complex settlements of commercial and intellectual property disputes involving life sciences technology.

Education